Global Biological Data Visualization Market

Biological Data Visualization Comprehensive Study by Application (Cell and Organism Imaging, Structural Biology and Molecular Modeling, Genomic Analysis, Alignments, Phylogeny, and Evolution, Systems Biology), Deployment (On-premise, Cloud), Technique (Microscopy, Magnetic Resonance Imaging, Sequencing, X-ray Crystallography, Others), End User (Academic Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users) Players and Region - Global Market Outlook to 2026

Biological Data Visualization Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biological Data Visualization Market?

Data visualization is an integral part of biological sciences and essential to enable dissemination of knowledge and sophisticated analysis of data. With advances in both biological data acquisition technologies and data-management and -processing technologies, researchers face challenges of developing better conjectures from the data that continue to increase in volume and complexity. The goal of biological data visualization is to support the development of analysis methods and the interpretation of results, encompassing both engineering and scientific research challenges.

The market study is being classified, by Application (Cell and Organism Imaging, Structural Biology and Molecular Modeling, Genomic Analysis, Alignments, Phylogeny, and Evolution and Systems Biology) and major geographies with country level break-up.

3M Company (United States), Thermo Fisher Scientific, Inc. (United States), Agilent Technologies, Inc. (United States), QIAGEN (Germany), Becton, Dickinson and Company (United States), Carl Zeiss (Germany), Olympus Corporation (Japan), Oxford Instruments plc (United Kingdom), Genedata AG (Switzerland), Clarivate (United States), Arivis AG (Germany) and Danaher Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Genialis, Inc. (United States), Scientific Volume Imaging B.V. (Netherlands), Media Cybernetics, Inc. (United States), Molecular Devices, LLC (United States), Plotly (Canada) and Advanced Visual Systems, Inc. (Canada).

Segment Analysis
Analyst at AMA have segmented the market study of Global Biological Data Visualization market by Type, Application and Region.

On the basis of geography, the market of Biological Data Visualization has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Cloud Deployment of Data Visualization Solutions
  • Need for Quick Decision Making

Market Trend
  • Demand for Image-Processing Integrated With Artificial Intelligence

Restraints
  • Lack of Computational Consistency

Opportunities
  • Advent of Virtual Reality Environment
  • Growth of Biological Data

Challenges
  • Lack of Technically Skilled Workforce


In July 2019, Olympus Corporation introduced scanR 3.1 High-content Screening Station (HCS), a modular microscope-based imaging platform. This platform uses artificial intelligence technology for the analysis of live cells and provide fully automated image acquisition and data analysis of biological samples.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Biological Data Visualization Providers, Technology Service Providers, Venture Capitalists and Private Equity Firms and Government Regulatory and Research Organizations

Report Objectives / Segmentation Covered

By Application
  • Cell and Organism Imaging
  • Structural Biology and Molecular Modeling
  • Genomic Analysis
  • Alignments, Phylogeny, and Evolution
  • Systems Biology
By Deployment
  • On-premise
  • Cloud

By Technique
  • Microscopy
  • Magnetic Resonance Imaging
  • Sequencing
  • X-ray Crystallography
  • Others

By End User
  • Academic Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Cloud Deployment of Data Visualization Solutions
      • 3.2.2. Need for Quick Decision Making
    • 3.3. Market Challenges
      • 3.3.1. Lack of Technically Skilled Workforce
    • 3.4. Market Trends
      • 3.4.1. Demand for Image-Processing Integrated With Artificial Intelligence
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biological Data Visualization, by Application, Deployment, Technique, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biological Data Visualization (Value)
      • 5.2.1. Global Biological Data Visualization by: Application (Value)
        • 5.2.1.1. Cell and Organism Imaging
        • 5.2.1.2. Structural Biology and Molecular Modeling
        • 5.2.1.3. Genomic Analysis
        • 5.2.1.4. Alignments, Phylogeny, and Evolution
        • 5.2.1.5. Systems Biology
      • 5.2.2. Global Biological Data Visualization by: Deployment (Value)
        • 5.2.2.1. On-premise
        • 5.2.2.2. Cloud
      • 5.2.3. Global Biological Data Visualization by: Technique (Value)
        • 5.2.3.1. Microscopy
        • 5.2.3.2. Magnetic Resonance Imaging
        • 5.2.3.3. Sequencing
        • 5.2.3.4. X-ray Crystallography
        • 5.2.3.5. Others
      • 5.2.4. Global Biological Data Visualization by: End User (Value)
        • 5.2.4.1. Academic Research
        • 5.2.4.2. Hospitals & Clinics
        • 5.2.4.3. Pharmaceutical & Biotechnology Companies
        • 5.2.4.4. Other Users
      • 5.2.5. Global Biological Data Visualization Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Biological Data Visualization: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. QIAGEN (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Carl Zeiss (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Olympus Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Oxford Instruments plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Genedata AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Clarivate (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Arivis AG (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Danaher Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Biological Data Visualization Sale, by Application, Deployment, Technique, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biological Data Visualization (Value)
      • 7.2.1. Global Biological Data Visualization by: Application (Value)
        • 7.2.1.1. Cell and Organism Imaging
        • 7.2.1.2. Structural Biology and Molecular Modeling
        • 7.2.1.3. Genomic Analysis
        • 7.2.1.4. Alignments, Phylogeny, and Evolution
        • 7.2.1.5. Systems Biology
      • 7.2.2. Global Biological Data Visualization by: Deployment (Value)
        • 7.2.2.1. On-premise
        • 7.2.2.2. Cloud
      • 7.2.3. Global Biological Data Visualization by: Technique (Value)
        • 7.2.3.1. Microscopy
        • 7.2.3.2. Magnetic Resonance Imaging
        • 7.2.3.3. Sequencing
        • 7.2.3.4. X-ray Crystallography
        • 7.2.3.5. Others
      • 7.2.4. Global Biological Data Visualization by: End User (Value)
        • 7.2.4.1. Academic Research
        • 7.2.4.2. Hospitals & Clinics
        • 7.2.4.3. Pharmaceutical & Biotechnology Companies
        • 7.2.4.4. Other Users
      • 7.2.5. Global Biological Data Visualization Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biological Data Visualization: by Application(USD Million)
  • Table 2. Biological Data Visualization Cell and Organism Imaging , by Region USD Million (2015-2020)
  • Table 3. Biological Data Visualization Structural Biology and Molecular Modeling , by Region USD Million (2015-2020)
  • Table 4. Biological Data Visualization Genomic Analysis , by Region USD Million (2015-2020)
  • Table 5. Biological Data Visualization Alignments, Phylogeny, and Evolution , by Region USD Million (2015-2020)
  • Table 6. Biological Data Visualization Systems Biology , by Region USD Million (2015-2020)
  • Table 7. Biological Data Visualization: by Deployment(USD Million)
  • Table 8. Biological Data Visualization On-premise , by Region USD Million (2015-2020)
  • Table 9. Biological Data Visualization Cloud , by Region USD Million (2015-2020)
  • Table 10. Biological Data Visualization: by Technique(USD Million)
  • Table 11. Biological Data Visualization Microscopy , by Region USD Million (2015-2020)
  • Table 12. Biological Data Visualization Magnetic Resonance Imaging , by Region USD Million (2015-2020)
  • Table 13. Biological Data Visualization Sequencing , by Region USD Million (2015-2020)
  • Table 14. Biological Data Visualization X-ray Crystallography , by Region USD Million (2015-2020)
  • Table 15. Biological Data Visualization Others , by Region USD Million (2015-2020)
  • Table 16. Biological Data Visualization: by End User(USD Million)
  • Table 17. Biological Data Visualization Academic Research , by Region USD Million (2015-2020)
  • Table 18. Biological Data Visualization Hospitals & Clinics , by Region USD Million (2015-2020)
  • Table 19. Biological Data Visualization Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 20. Biological Data Visualization Other Users , by Region USD Million (2015-2020)
  • Table 21. South America Biological Data Visualization, by Country USD Million (2015-2020)
  • Table 22. South America Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 23. South America Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 24. South America Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 25. South America Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 26. Brazil Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 27. Brazil Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 28. Brazil Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 29. Brazil Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 30. Argentina Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 31. Argentina Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 32. Argentina Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 33. Argentina Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 34. Rest of South America Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 36. Rest of South America Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 37. Rest of South America Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 38. Asia Pacific Biological Data Visualization, by Country USD Million (2015-2020)
  • Table 39. Asia Pacific Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 41. Asia Pacific Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 42. Asia Pacific Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 43. China Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 44. China Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 45. China Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 46. China Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 47. Japan Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 48. Japan Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 49. Japan Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 50. Japan Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 51. India Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 52. India Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 53. India Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 54. India Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 55. South Korea Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 56. South Korea Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 57. South Korea Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 58. South Korea Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 59. Taiwan Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 60. Taiwan Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 61. Taiwan Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 62. Taiwan Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 63. Australia Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 64. Australia Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 65. Australia Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 66. Australia Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 71. Europe Biological Data Visualization, by Country USD Million (2015-2020)
  • Table 72. Europe Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 73. Europe Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 74. Europe Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 75. Europe Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 76. Germany Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 77. Germany Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 78. Germany Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 79. Germany Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 80. France Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 81. France Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 82. France Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 83. France Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 84. Italy Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 85. Italy Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 86. Italy Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 87. Italy Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 88. United Kingdom Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 90. United Kingdom Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 91. United Kingdom Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 92. Netherlands Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 93. Netherlands Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 94. Netherlands Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 95. Netherlands Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 96. Rest of Europe Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 98. Rest of Europe Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 99. Rest of Europe Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 100. MEA Biological Data Visualization, by Country USD Million (2015-2020)
  • Table 101. MEA Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 102. MEA Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 103. MEA Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 104. MEA Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 105. Middle East Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 106. Middle East Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 107. Middle East Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 108. Middle East Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 109. Africa Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 110. Africa Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 111. Africa Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 112. Africa Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 113. North America Biological Data Visualization, by Country USD Million (2015-2020)
  • Table 114. North America Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 115. North America Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 116. North America Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 117. North America Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 118. United States Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 119. United States Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 120. United States Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 121. United States Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 122. Canada Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 123. Canada Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 124. Canada Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 125. Canada Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 126. Mexico Biological Data Visualization, by Application USD Million (2015-2020)
  • Table 127. Mexico Biological Data Visualization, by Deployment USD Million (2015-2020)
  • Table 128. Mexico Biological Data Visualization, by Technique USD Million (2015-2020)
  • Table 129. Mexico Biological Data Visualization, by End User USD Million (2015-2020)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Biological Data Visualization: by Application(USD Million)
  • Table 143. Biological Data Visualization Cell and Organism Imaging , by Region USD Million (2021-2026)
  • Table 144. Biological Data Visualization Structural Biology and Molecular Modeling , by Region USD Million (2021-2026)
  • Table 145. Biological Data Visualization Genomic Analysis , by Region USD Million (2021-2026)
  • Table 146. Biological Data Visualization Alignments, Phylogeny, and Evolution , by Region USD Million (2021-2026)
  • Table 147. Biological Data Visualization Systems Biology , by Region USD Million (2021-2026)
  • Table 148. Biological Data Visualization: by Deployment(USD Million)
  • Table 149. Biological Data Visualization On-premise , by Region USD Million (2021-2026)
  • Table 150. Biological Data Visualization Cloud , by Region USD Million (2021-2026)
  • Table 151. Biological Data Visualization: by Technique(USD Million)
  • Table 152. Biological Data Visualization Microscopy , by Region USD Million (2021-2026)
  • Table 153. Biological Data Visualization Magnetic Resonance Imaging , by Region USD Million (2021-2026)
  • Table 154. Biological Data Visualization Sequencing , by Region USD Million (2021-2026)
  • Table 155. Biological Data Visualization X-ray Crystallography , by Region USD Million (2021-2026)
  • Table 156. Biological Data Visualization Others , by Region USD Million (2021-2026)
  • Table 157. Biological Data Visualization: by End User(USD Million)
  • Table 158. Biological Data Visualization Academic Research , by Region USD Million (2021-2026)
  • Table 159. Biological Data Visualization Hospitals & Clinics , by Region USD Million (2021-2026)
  • Table 160. Biological Data Visualization Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 161. Biological Data Visualization Other Users , by Region USD Million (2021-2026)
  • Table 162. South America Biological Data Visualization, by Country USD Million (2021-2026)
  • Table 163. South America Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 164. South America Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 165. South America Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 166. South America Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 167. Brazil Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 168. Brazil Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 169. Brazil Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 170. Brazil Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 171. Argentina Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 172. Argentina Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 173. Argentina Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 174. Argentina Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 175. Rest of South America Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 176. Rest of South America Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 177. Rest of South America Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 178. Rest of South America Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 179. Asia Pacific Biological Data Visualization, by Country USD Million (2021-2026)
  • Table 180. Asia Pacific Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 181. Asia Pacific Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 182. Asia Pacific Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 183. Asia Pacific Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 184. China Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 185. China Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 186. China Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 187. China Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 188. Japan Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 189. Japan Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 190. Japan Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 191. Japan Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 192. India Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 193. India Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 194. India Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 195. India Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 196. South Korea Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 197. South Korea Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 198. South Korea Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 199. South Korea Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 200. Taiwan Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 201. Taiwan Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 202. Taiwan Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 203. Taiwan Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 204. Australia Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 205. Australia Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 206. Australia Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 207. Australia Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 208. Rest of Asia-Pacific Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 209. Rest of Asia-Pacific Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 210. Rest of Asia-Pacific Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 212. Europe Biological Data Visualization, by Country USD Million (2021-2026)
  • Table 213. Europe Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 214. Europe Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 215. Europe Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 216. Europe Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 217. Germany Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 218. Germany Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 219. Germany Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 220. Germany Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 221. France Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 222. France Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 223. France Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 224. France Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 225. Italy Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 226. Italy Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 227. Italy Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 228. Italy Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 229. United Kingdom Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 230. United Kingdom Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 231. United Kingdom Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 232. United Kingdom Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 233. Netherlands Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 234. Netherlands Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 235. Netherlands Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 236. Netherlands Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 237. Rest of Europe Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 238. Rest of Europe Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 239. Rest of Europe Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 240. Rest of Europe Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 241. MEA Biological Data Visualization, by Country USD Million (2021-2026)
  • Table 242. MEA Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 243. MEA Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 244. MEA Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 245. MEA Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 246. Middle East Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 247. Middle East Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 248. Middle East Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 249. Middle East Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 250. Africa Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 251. Africa Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 252. Africa Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 253. Africa Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 254. North America Biological Data Visualization, by Country USD Million (2021-2026)
  • Table 255. North America Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 256. North America Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 257. North America Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 258. North America Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 259. United States Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 260. United States Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 261. United States Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 262. United States Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 263. Canada Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 264. Canada Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 265. Canada Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 266. Canada Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 267. Mexico Biological Data Visualization, by Application USD Million (2021-2026)
  • Table 268. Mexico Biological Data Visualization, by Deployment USD Million (2021-2026)
  • Table 269. Mexico Biological Data Visualization, by Technique USD Million (2021-2026)
  • Table 270. Mexico Biological Data Visualization, by End User USD Million (2021-2026)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biological Data Visualization: by Application USD Million (2015-2020)
  • Figure 5. Global Biological Data Visualization: by Deployment USD Million (2015-2020)
  • Figure 6. Global Biological Data Visualization: by Technique USD Million (2015-2020)
  • Figure 7. Global Biological Data Visualization: by End User USD Million (2015-2020)
  • Figure 8. South America Biological Data Visualization Share (%), by Country
  • Figure 9. Asia Pacific Biological Data Visualization Share (%), by Country
  • Figure 10. Europe Biological Data Visualization Share (%), by Country
  • Figure 11. MEA Biological Data Visualization Share (%), by Country
  • Figure 12. North America Biological Data Visualization Share (%), by Country
  • Figure 13. Global Biological Data Visualization share by Players 2020 (%)
  • Figure 14. Global Biological Data Visualization share by Players (Top 3) 2020(%)
  • Figure 15. Global Biological Data Visualization share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. 3M Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. 3M Company (United States) Revenue: by Geography 2020
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Agilent Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 24. QIAGEN (Germany) Revenue: by Geography 2020
  • Figure 25. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 27. Carl Zeiss (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Carl Zeiss (Germany) Revenue: by Geography 2020
  • Figure 29. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Olympus Corporation (Japan) Revenue: by Geography 2020
  • Figure 31. Oxford Instruments plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Oxford Instruments plc (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Genedata AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Genedata AG (Switzerland) Revenue: by Geography 2020
  • Figure 35. Clarivate (United States) Revenue, Net Income and Gross profit
  • Figure 36. Clarivate (United States) Revenue: by Geography 2020
  • Figure 37. Arivis AG (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Arivis AG (Germany) Revenue: by Geography 2020
  • Figure 39. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 41. Global Biological Data Visualization: by Application USD Million (2021-2026)
  • Figure 42. Global Biological Data Visualization: by Deployment USD Million (2021-2026)
  • Figure 43. Global Biological Data Visualization: by Technique USD Million (2021-2026)
  • Figure 44. Global Biological Data Visualization: by End User USD Million (2021-2026)
  • Figure 45. South America Biological Data Visualization Share (%), by Country
  • Figure 46. Asia Pacific Biological Data Visualization Share (%), by Country
  • Figure 47. Europe Biological Data Visualization Share (%), by Country
  • Figure 48. MEA Biological Data Visualization Share (%), by Country
  • Figure 49. North America Biological Data Visualization Share (%), by Country
List of companies from research coverage that are profiled in the study
  • 3M Company (United States)
  • Thermo Fisher Scientific, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • QIAGEN (Germany)
  • Becton, Dickinson and Company (United States)
  • Carl Zeiss (Germany)
  • Olympus Corporation (Japan)
  • Oxford Instruments plc (United Kingdom)
  • Genedata AG (Switzerland)
  • Clarivate (United States)
  • Arivis AG (Germany)
  • Danaher Corporation (United States)
Additional players considered in the study are as follows:
Genialis, Inc. (United States) , Scientific Volume Imaging B.V. (Netherlands) , Media Cybernetics, Inc. (United States) , Molecular Devices, LLC (United States) , Plotly (Canada) , Advanced Visual Systems, Inc. (Canada)
Select User Access Type

Key Highlights of Report


Jun 2021 230 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biological Data Visualization Market Quantitative research analysis
Global Biological Data Visualization Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Cloud Deployment of Data Visualization Solutions " is seen as one of major growth factors of Biological Data Visualization Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
will lead the Biological Data Visualization Market.

Know More About Global Biological Data Visualization Market Report?

Have a Query? Click Here

Other Related Reports

ePRO, E-Patient Diaries and eCOA Comprehensive Study by Type (ECOA (Electronic Clinical Outcome Assessments), EPROs (Patient-Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observe...
$ 3750
Blockchain Technology in Transportation and Logistics Comprehensive Study by Type (Software, Service), Organization Size (Small & Medium-Sized Enterprises, Large Enterprises), Blockchain Type (Public...
$ 3450
Big Data Technology & Services Comprehensive Study by Deployment Mode (On-Premises, Cloud/On-Demand), Industries (BFSI, Retail, Aerospace and Defense, Media and Entertainment, Healthcare and Pharmace...
$ 3750
Blockchain In Genomics Comprehensive Study by Type (Public, Federated, Private), Application (Clinical Trials, IP Management, Drug Discovery, Data storage and security, Others), Target (B2B, B2C, C2C...
$ 3650
Augmented Intelligence Comprehensive Study by End-users (IT and Telecommunication, Retail and E-Commerce, BFSI, Healthcare, Others), Technology (Machine Learning, Natural Language Processing, Context...
$ 3450
Beacons Technology Comprehensive Study by Connectivity (Bluetooth Low Energy (BLE), Hybrid), Industry Verticals (Retail, Public Gatherings & Spaces, Hospitality, Transportation & Logistics, Sports, ...
$ 3750